The Supreme Court’s recent unanimous decision on FDA’s drug-approval authority is utterly unremarkable.

A unanimous Supreme Court instructed the Fifth Circuit to reconsider the harmless error rule for agency action.

Kennedy, a case that concerns how hospitals that treat a large share of low-income patients are paid by the Medicare program.

The Supreme Court preserves preventive services coverage but emboldens the HHS Secretary.

Scholars consider the antitrust implications of advances in AI-driven algorithmic pricing.

The Supreme Court runs afoul of its own equal protection doctrine by ignoring explicit classifications.

Scholars examine the dangers of difficult-to-understand AI in criminal investigations and cases. Artificial intelligence (AI) ...

Lawrence O. Gostin discusses the importance of equity and science in the face of threats to global health security.

Scholar argues for an approach to regulating artificial intelligence centered on mental health.

The Supreme Court allows Department of Education layoffs, a federal court upholds a mifepristone ban, and ...

Scholars and practitioners examine the Court’s most important regulatory decisions of this past term.

When a project like the rail line has significant environmental impacts, NEPA requires a “detailed statement” that discusses the project’s negative environmental effects and reasonable alternatives.